Publisher Correction to: Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry

Dermatol Ther (Heidelb). 2024 Apr 9. doi: 10.1007/s13555-024-01118-y. Online ahead of print.

Authors

Eric L Simpson¹, Ben Lockshin², Lara Wine Lee³, Zhen Chen⁴, Moataz Daoud⁵, Andrew Korotzer⁴

Affiliations

¹ Department of Dermatology, Oregon Health and Science University, Portland, OR, USA. simpsone@ohsu.edu.
² Department of Dermatology, Georgetown University, Washington, DC, USA.
³ Medical University of South Carolina, Charleston, SC, USA.
⁴ Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
⁵ Sanofi, Cambridge, MA, USA.

PMID: 38594567
DOI: 10.1007/s13555-024-01118-y

No abstract available

Publication types

Published Erratum